Sustained efficacy with long-term treatment with AXS-05: Results from the comet phase 3 trial, a long-term, open open-label study evaluating the efficacy and safety of AXS-05 for the treatment of MDD
After 2 h, the second scan with [ 11 C]raclopride was started following administration of IV NAL that was given in 0.01 mg/kg increments (every 4 min) until withdrawal symptoms appeared (e.g., yawning, abdominal cramps, rhinorrhea, and tearing) [6]
[10] It is worth being exact about what that source says, because the naive reading goes too far in the other direction: the recommendation is to adjust the parenteral copper dose according to serum concentrations and the clinical picture, explicitly not to stop it, since discontinuing copper in cholestatic patients risks producing copper deficiency instead
As a nutritionist and mindset coach, I do not recommend or sell peptides, but I do educate clients about the evolving landscape of gut health tools and that includes peptides like BPC-157
Growth hormone stimulates collagen synthesis, and sermorelin users frequently report improvements in skin quality within weeks to months of beginning protocols